Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones

Based on molecular docking studies on the ERα, a series of lignan derivatives (<b>3</b>–<b>16</b>) were designed and semisynthesized from the natural dibenzylbutyrolactones bursehernin (<b>1</b>) and matairesinol dimethyl ether (<b>2</b>). To examine t...

Full description

Bibliographic Details
Main Authors: Priscila López-Rojas, Ángel Amesty, Miguel Guerra-Rodríguez, Yeray Brito-Casillas, Borja Guerra, Leandro Fernández-Pérez, Ana Estévez-Braun
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/15/5/585
_version_ 1797496849897095168
author Priscila López-Rojas
Ángel Amesty
Miguel Guerra-Rodríguez
Yeray Brito-Casillas
Borja Guerra
Leandro Fernández-Pérez
Ana Estévez-Braun
author_facet Priscila López-Rojas
Ángel Amesty
Miguel Guerra-Rodríguez
Yeray Brito-Casillas
Borja Guerra
Leandro Fernández-Pérez
Ana Estévez-Braun
author_sort Priscila López-Rojas
collection DOAJ
description Based on molecular docking studies on the ERα, a series of lignan derivatives (<b>3</b>–<b>16</b>) were designed and semisynthesized from the natural dibenzylbutyrolactones bursehernin (<b>1</b>) and matairesinol dimethyl ether (<b>2</b>). To examine their estrogenic and antiestrogenic potencies, the effects of these compounds on estrogen receptor element (ERE)-driven reporter gene expression and viability in human ER+ breast cancer cells were evaluated. Lignan compounds induced ERE-driven reporter gene expression with very low potency as compared with the pure agonist E2. However, coincubation of 5 μM of lignan derivatives <b>1</b>, <b>3</b>, <b>4</b>, <b>7</b>, <b>8</b>, <b>9</b>, <b>11</b>, <b>13</b>, and <b>14</b> with increasing concentrations of E2 (from 0.01 pM to 1 nM) reduced both the potency and efficacy of pure agonists. The binding to the rhERα-LBD was validated by TR-FRET competitive binding assay and lignans bound to the rhERα with IC<sub>50</sub> values from 0.16 μM (compound <b>14</b>) to 6 μM (compound <b>4</b>). Induced fit docking (IFD) and molecular dynamics (MD) simulations for compound <b>14</b> were carried out to further investigate the binding mode interactions. Finally, the in silico ADME predictions indicated that the most potent lignan derivatives exhibited good drug-likeness.
first_indexed 2024-03-10T03:09:25Z
format Article
id doaj.art-58ab08d216af458aa014a9b64bba7b9c
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T03:09:25Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-58ab08d216af458aa014a9b64bba7b9c2023-11-23T12:34:56ZengMDPI AGPharmaceuticals1424-82472022-05-0115558510.3390/ph15050585Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural DibenzylbutyrolactonesPriscila López-Rojas0Ángel Amesty1Miguel Guerra-Rodríguez2Yeray Brito-Casillas3Borja Guerra4Leandro Fernández-Pérez5Ana Estévez-Braun6Departamento de Química Orgánica, Instituto Universitario de Bio-Orgánica, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez 2, 38206 La Laguna, Tenerife, SpainDepartamento de Química Orgánica, Instituto Universitario de Bio-Orgánica, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez 2, 38206 La Laguna, Tenerife, SpainInstituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), Universidad de Las Palmas de Gran Canaria (ULPGC), Paseo Blas Cabrera Felipe s/n, 35016 Las Palmas de Gran Canaria, SpainInstituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), Universidad de Las Palmas de Gran Canaria (ULPGC), Paseo Blas Cabrera Felipe s/n, 35016 Las Palmas de Gran Canaria, SpainInstituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), Universidad de Las Palmas de Gran Canaria (ULPGC), Paseo Blas Cabrera Felipe s/n, 35016 Las Palmas de Gran Canaria, SpainInstituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), Universidad de Las Palmas de Gran Canaria (ULPGC), Paseo Blas Cabrera Felipe s/n, 35016 Las Palmas de Gran Canaria, SpainDepartamento de Química Orgánica, Instituto Universitario de Bio-Orgánica, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez 2, 38206 La Laguna, Tenerife, SpainBased on molecular docking studies on the ERα, a series of lignan derivatives (<b>3</b>–<b>16</b>) were designed and semisynthesized from the natural dibenzylbutyrolactones bursehernin (<b>1</b>) and matairesinol dimethyl ether (<b>2</b>). To examine their estrogenic and antiestrogenic potencies, the effects of these compounds on estrogen receptor element (ERE)-driven reporter gene expression and viability in human ER+ breast cancer cells were evaluated. Lignan compounds induced ERE-driven reporter gene expression with very low potency as compared with the pure agonist E2. However, coincubation of 5 μM of lignan derivatives <b>1</b>, <b>3</b>, <b>4</b>, <b>7</b>, <b>8</b>, <b>9</b>, <b>11</b>, <b>13</b>, and <b>14</b> with increasing concentrations of E2 (from 0.01 pM to 1 nM) reduced both the potency and efficacy of pure agonists. The binding to the rhERα-LBD was validated by TR-FRET competitive binding assay and lignans bound to the rhERα with IC<sub>50</sub> values from 0.16 μM (compound <b>14</b>) to 6 μM (compound <b>4</b>). Induced fit docking (IFD) and molecular dynamics (MD) simulations for compound <b>14</b> were carried out to further investigate the binding mode interactions. Finally, the in silico ADME predictions indicated that the most potent lignan derivatives exhibited good drug-likeness.https://www.mdpi.com/1424-8247/15/5/585natural productslignansestrogenic and antiestrogenic activitiesinduced fit docking (IFD)molecular dynamics (MD)
spellingShingle Priscila López-Rojas
Ángel Amesty
Miguel Guerra-Rodríguez
Yeray Brito-Casillas
Borja Guerra
Leandro Fernández-Pérez
Ana Estévez-Braun
Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones
Pharmaceuticals
natural products
lignans
estrogenic and antiestrogenic activities
induced fit docking (IFD)
molecular dynamics (MD)
title Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones
title_full Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones
title_fullStr Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones
title_full_unstemmed Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones
title_short Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones
title_sort design semisynthesis and estrogenic activity of lignan derivatives from natural dibenzylbutyrolactones
topic natural products
lignans
estrogenic and antiestrogenic activities
induced fit docking (IFD)
molecular dynamics (MD)
url https://www.mdpi.com/1424-8247/15/5/585
work_keys_str_mv AT priscilalopezrojas designsemisynthesisandestrogenicactivityoflignanderivativesfromnaturaldibenzylbutyrolactones
AT angelamesty designsemisynthesisandestrogenicactivityoflignanderivativesfromnaturaldibenzylbutyrolactones
AT miguelguerrarodriguez designsemisynthesisandestrogenicactivityoflignanderivativesfromnaturaldibenzylbutyrolactones
AT yeraybritocasillas designsemisynthesisandestrogenicactivityoflignanderivativesfromnaturaldibenzylbutyrolactones
AT borjaguerra designsemisynthesisandestrogenicactivityoflignanderivativesfromnaturaldibenzylbutyrolactones
AT leandrofernandezperez designsemisynthesisandestrogenicactivityoflignanderivativesfromnaturaldibenzylbutyrolactones
AT anaestevezbraun designsemisynthesisandestrogenicactivityoflignanderivativesfromnaturaldibenzylbutyrolactones